Ikuyo Imayama

Ms. Ikuyo Imayama


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Social Science & Medicine
Verified
Journal Article
Closed access
NKNandini Karunamuni
Nandini Karunamuni
IIIkuyo Imayama
Ikuyo Imayama
DGDharshini Goonetilleke
Dharshini Goonetilleke

16 October 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DSDamini Saxena
Damini Saxena
IIIkuyo Imayama
Ikuyo Imayama
Muhammad AdrishMuhammad Adrish
Muhammad Adrish
Asthma and obstructive sleep apnea are highly prevalent conditions with a high cost burden. In addition to shared risk factors, existing data suggest a bidirectional relationship between asthma and OSA, where each condition can impact the other. Patients with asthma often complain of sleep fragmentation, nocturnal asthma symptoms, daytime sleepiness, and snoring. The prevalence of OSA increases with asthma severity, as evidenced by multiple large studies. Asthma may lower the threshold for arousal in OSA, resulting in the hypopnea with arousal phenotype. Epidemiologic studies in adults have shown that OSA is associated with worse asthma severity, increased frequency of exacerbation, and poor quality of life. The current literature assessing the relationship among OSA, asthma, and CPAP therapy is heavily dependent on observational studies. There is a need for randomized controlled trials to minimize the interference of confounding shared risk factors.

23 November 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
IIIkuyo Imayama
Ikuyo Imayama
BBBilgay Izci Balserak
Bilgay Izci Balserak
AGAhana Gupta
Ahana Gupta
TMTomas Munoz
Tomas Munoz
MSManassawee Srimoragot
Manassawee Srimoragot
Bharati PrasadBharati Prasad
Bharati Prasad
It is unclear if the response to positive airway pressure (PAP) treatment is different between African American (AA) and European Americans (EA). We examined whether race modifies the effects of PAP on sleep and daytime function. We assessed Epworth Sleepiness Scale (ESS), Functional Outcomes of Sleep Questionnaire, Psychomotor Vigilance Task and actigraphy in 185 participants with moderate-to-severe obstructive sleep apnea before and 3–4 months after PAP treatment. The participants were middle-aged (mean, 55.1 years), 83.8% men and 60.5% AA. Linear regression models were used to examine the effect of race on outcomes. The AA had smaller reductions in ESS (mean change (95% confidence interval, CI) AA, −2.30 [−3.35, −1.25] vs. EA, −4.16 [−5.48, −2.84] and frequency of awakenings (AA, −0.73 [−4.92, 3.47] vs. EA, −9.35 [−15.20, −3.51]). A race × PAP usage interaction term was added to the model to examine if the change in outcomes per 1 h increase in PAP usage differed by race. AA exhibited greater improvement in wake after sleep onset (β (95% CI) AA, −8.89 [−16.40, −1.37] vs. EA, 2.49 [−4.15, 9.12]) and frequency of awakening (β (95% CI) AA, −2.59 [−4.44, −0.75] vs. EA, 1.71 [−1.08, 4.50]). The results indicate the importance of race in evaluating outcomes following PAP treatment.

1 May 2020
Verified
Conference Paper
Open access
AMA. Mathew
A. Mathew
SKS. Krow
S. Krow
MKMarcus Kaul
Marcus Kaul
SKS. Kalra
S. Kalra
IIIkuyo Imayama
Ikuyo Imayama
SSSunit Singla
Sunit Singla

26 February 2023 in Journal of Sleep Research
Verified
Journal Article
Open access
IIIkuyo Imayama
Ikuyo Imayama
CGCollin Gallagher
Collin Gallagher
JGJacob Grand
Jacob Grand
BFBenjamin Follman
Benjamin Follman
MKMayank Kansal
Mayank Kansal
BPBharati Prasad
Bharati Prasad
Summary: Although studies have shown that continuous positive airway pressure (CPAP) therapy to treat obstructive sleep apnea improves left ventricular diastolic function, modifiers of improvement are unknown. We explored race and pre‐treatment 24‐h non‐dipping blood pressure status as modifiers of improved diastolic function. Participants (N = 220) with obstructive sleep apnea (apnea–hypopnea index ≥15 events/h) and hypertension were recruited to a cohort study that examined effects of 3‐month CPAP therapy on 24‐h blood pressure. Those who completed echocardiogram at baseline and follow‐up were included in this analysis. Diastolic function parameters (E, A, e′, E/A, E/e′) were assessed. Race was categorised to African American versus others. Participants were categorised as nocturnal dippers (night‐time blood pressure decrease by ≥10%) versus non‐dippers. We compared changes in parameters of diastolic function by race and nocturnal dipping status. A total of 92 participants were included. They were men (86%), African American (67.4%), and current smoker (29.5%). Mean apnea–hypopnea index was 32.9 events/h. Mean CPAP usage was 3.15 h/day. After 3 months of CPAP treatment, there were significant improvements in measures of diastolic function: a median (interquartile range [IQR]) increase in E velocity by 4.00 (−5.75 to 13.75) cm/s, an increase in e′ by 2.00 (0–4.00) cm/s, and a decrease in the E/e′ ratio by 1.74 (−4.27 to 0.00) at follow‐up (p < 0.05). These changes did not differ by race or nocturnal dipping status. Improvements in diastolic function after CPAP therapy did not differ by race or nocturnal dipping status. Further studies are needed to understand predictors of CPAP effects on diastolic function.

1 May 2021 in JACC
Verified
Journal Article
Closed access
CGColin Gallagher
Colin Gallagher
JGJacob Grand
Jacob Grand
IIIkuyo Imayama
Ikuyo Imayama
BFBenjamin Follman
Benjamin Follman
Bharati PrasadBharati Prasad
Bharati Prasad
MKMayank Kansal
Mayank Kansal